WASHINGTON, Sept. 23, 2019 /PRNewswire/ -- Children's National Hospital and the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announce…
BALTIMORE, Sept. 23, 2019 /PRNewswire/ — KaloCyte, a preclinical-stage healthcare biotechnology company developing a synthetic, bio-inspired red blood cell substitute…
CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--LumaCyte, an advanced research and bioanalytics instrumentation company headquartered in Charlottesville, VA, announces the third doubling of their…